Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Prostatic Neoplasms × Injections, Subcutaneous × 1 year × Clear all

Sponsor

Conditions

Breast Neoplasms 3 Multiple Myeloma 2 Squamous Cell Carcinoma of Head and Neck 1 Recurrent Metastatic Non-Squamous Non Small Cell Lung Cancer 1 Patient Preference 1 Inflammatory Breast Neoplasms 1 Colorectal Neoplasms 1 Carcinoma, Non-Small-Cell Lung 1 CD20-positive Hematological Malignancies 1 Bile Duct Neoplasms 1 Advanced Cancers 1

Interventions

enzalutamide 83 Magnetic Resonance Spectroscopy 81 Prednisone 63 Specimen Handling 62 Abiraterone Acetate 60 apalutamide 52 Androgen Antagonists 50 Radiosurgery 49 Leuprolide 47 Radiotherapy 43 Docetaxel 40 darolutamide 39 abiraterone 34 acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 30 Pluvicto 30 Radiation 28 Biopsy 28 Goserelin 27 pembrolizumab 25 gallium 68 PSMA-11 25 Triptorelin Pamoate 24 relugolix 23 bicalutamide 22 Surveys and Questionnaires 22 Standard of Care 22 Brachytherapy 22 Gonadotropin-Releasing Hormone 21 Carboplatin 20 cabazitaxel 19 X-Rays 18

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡